Pharvaris announced the appointment of Stefan Abele, Ph.D., as Chief Technical Operations Officer. In this role, he will be responsible for all chemistry, manufacturing, and controls activities, supply chain, and program management as Pharvaris progresses into late-stage clinical development. Dr. Abele joins Pharvaris with more than 20 years of experience in process development, end-to-end Active Pharmaceutical Ingredients supply chain, cross-functional CMC activities, GMP manufacturing, global vendor management, and people leadership.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PHVS:
- Pharvaris Appoints Stefan Abele, Ph.D., as Chief Technical Operations Officer
- Pharvaris Presents Deucrictibant Clinical Data and Real-World HAE Treatment Satisfaction Data at ACAAI 2023 Annual Scientific Meeting
- Pharvaris presents clinical data on deucrictibant, real-world HAE treatment
- Pharvaris Reports Third Quarter 2023 Financial Results and Provides Business Update
- Pharvaris To Present at the ACAAI 2023 Annual Scientific Meeting